Acceptability and tolerability of long-acting injectable cabotegravir-rilpivirine in adolescents with HIV-1 (IMPAACT 2017/MOCHA): 48-week results of a multicentre, open-label, non-comparative phase 1/2 trial
长效注射用卡博特韦-利匹韦林在HIV-1感染青少年中的可接受性和耐受性（IMPAACT 2017/MOCHA）：一项多中心、开放标签、非对照1/2期试验的48周结果
期刊:Lancet HIV
影响因子:13
doi:10.1016/S2352-3018(25)00241-3
Lowenthal, Elizabeth D; Chapman, Jennifer; Baltrusaitis, Kristin; Kovic, Grace; Merchant, Sanjna; Branch, Kaleb; Tsosie, Chermiqua; Vaca, Martina Zapata; Heckman, Barbara; Van Solingen-Ristea, Rodica M; Harrington, Conn M; Yin, Dwight E; Townley, Ellen; Whitton, Michael; Agwu, Allison L; Smith, Christiana; Paul, Mary E; Violari, Avy; Moodley, Evette; Owor, Maxensia; Chokephaibulkit, Kulkanya; Fry, Samantha; Jao, Jennifer; Mitchell, Charles D; Buisson, Sarah; Ace, Andi; Kolobova, Irina; Bolton-Moore, Carolyn; Gaur, Aditya H
